Human induced pluripotent stem cells derived cardiomyocytes (hiPSC-CM) are increasingly used to study genetic diseases on a human background. However, the lack of a fully mature adult cardiomyocyte phenotype of hiPSC-CM may be limiting the scope of these studies. Muscular dystrophies and concomitant cardiomyopathies result from mutations in genes encoding proteins of the dystrophin-associated protein complex (DAPC), which is a multi-protein membrane-spanning complex. We examined the expression of DAPC components in hiPSC-CM, which underwent maturation in 2D and 3D culture protocols. The results were compared with human adult cardiac tissue and isolated cardiomyocytes. We found that similarly to adult cardiomyocytes, hiPSC-CM express dystrophin, in line with previous studies on Duchenne's disease. β-dystroglycan was also expressed, but, contrary to findings in adult cardiomyocytes, none of the sarcoglycans nor α-dystroglycan were, despite the presence of their mRNA. In conclusion, despite the robust expression of dystrophin, the absence of several other DAPC protein components cautions for reliance on commonly used protocols for hiPSC-CM maturation for functional assessment of the complete DAPC.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599983 | PMC |
| http://dx.doi.org/10.3389/fcell.2021.737840 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Native DGC structure rationalizes muscular dystrophy-causing mutations.
Nature
December 2024
Department of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles, Los Angeles, CA, USA.
Duchenne muscular dystrophy (DMD) is a severe X-linked recessive disorder marked by progressive muscle wasting leading to premature mortality. Discovery of the DMD gene encoding dystrophin both revealed the cause of DMD and helped identify a family of at least ten dystrophin-associated proteins at the muscle cell membrane, collectively forming the dystrophin-glycoprotein complex (DGC). The DGC links the extracellular matrix to the cytoskeleton, but, despite its importance, its molecular architecture has remained elusive.
View Article and Find Full Text PDFRegulation of miR-206 in denervated and dystrophic muscles, and its effect on acetylcholine receptor clustering.
J Cell Sci
December 2024
Department of Molecular, Cellular and Developmental Biology, 1105 N. University Avenue, Ann Arbor, MI 48109, USA.
The muscle-specific microRNA miR-206 has recently emerged as a potential regulator of genes involved in the formation and regeneration of the neuromuscular junction (NMJ). This study investigated miR-206-3p (miR-206) expression in synaptic and non-synaptic regions of denervated mice and α-dystrobrevin (Dtna)-knockout mice, as well as its impact on the formation and/or maintenance of agrin-induced acetylcholine receptor (AChR) clusters. In denervated, Dtna-deficient and crushed muscles, miR-206 expression significantly increased compared to what was seen for innervated muscles.
View Article and Find Full Text PDFBiophysical characterization of the dystrophin C-terminal domain: Dystrophin interacts differentially with dystrobrevin isoforms.
J Biol Chem
December 2024
Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA. Electronic address:
Article Synopsis
- Duchenne muscular dystrophy (DMD) is caused by a mutation in the dystrophin gene, leading to a lack of functional dystrophin protein, resulting in muscle degeneration, and although some targeted therapies exist, they have limited effectiveness and are expensive.
- The structure and function of the C-terminal (CT) domain of dystrophin, which interacts with dystrobrevin to stabilize muscle cell membranes, are not well understood, posing challenges for treatment development.
- Research indicates that the CT domain is non-globular and interacts differently with two isoforms of dystrobrevin, revealing how variations in their amino acid composition can affect the stability of the dystrophin-associated glycoprotein
Dystrobrevin beta is a promising prognostic biomarker and therapeutic target for hepatocellular carcinoma.
Am J Transl Res
October 2024
National and Local Joint Engineering Research Center of Biodiagnostics and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University Xi'an 710004, Shaanxi, China.
Article Synopsis
- Dystrobrevin beta (DTNB) is part of the dystrophin-associated protein complex and its expression is influenced by the long noncoding RNA (lncRNA) HOXD-AS1, particularly in hepatocellular carcinoma (HCC) cells.
- High levels of DTNB in HCC are linked to various clinical factors like tumor stage and prognosis, indicating its role as an independent risk marker for patient survival.
- Investigations suggest DTNB regulates the cell cycle and is involved in immune responses and drug sensitivity in HCC, with a potential regulatory mechanism involving a ceRNA network with HOXD-AS1 and miR-139-3p.
Compound heterozygous RYR1-RM mouse model reveals disease pathomechanisms and muscle adaptations to promote postnatal survival.
FASEB J
October 2024
Department of Pharmacology and Physiology, University of Rochester Medical Center, Rochester, New York, USA.
Pathogenic variants in the type I ryanodine receptor (RYR1) result in a wide range of muscle disorders referred to as RYR1-related myopathies (RYR1-RM). We developed the first RYR1-RM mouse model resulting from co-inheritance of two different RYR1 missense alleles (Ryr1 mice). Ryr1 mice exhibit a severe, early onset myopathy characterized by decreased body/muscle mass, muscle weakness, hypotrophy, reduced RYR1 expression, and unexpectedly, incomplete postnatal lethality with a plateau survival of ~50% at 12 weeks of age.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!